FAKTOR-OPTIONSSCHEIN - VIRBAC | Market Closed - Börse Stuttgart 10:38:59 2024-07-12 am EDT | ||
| 7.6 EUR | -12.04% |
|
| Current month | -26.57% | ||
| 1 month | -9.31% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
VIRBAC
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 7.6 | -12.04% |
| 24-07-11 | 8.64 | +4.47% |
| 24-07-10 | 8.27 | -2.13% |
| 24-07-09 | 8.45 | +8.33% |
| 24-07-08 | 7.8 | +1.04% |
Delayed Quote Börse Stuttgart
Last update July 12, 2024 at 10:38 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | VIRBAC |
| Issuer | Morgan Stanley |
| WKN | MG1KHS |
| ISIN | DE000MG1KHS1 |
| Date issued | 2024-04-03 |
| Strike | 458.7 € |
| Maturity | Unlimited |
| Parity | 13.23 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.65 € |
|---|---|
| Lowest since issue | 7.6 € |
| Spread | 0.12 € |
| Spread % | 1.56% |
Company Profile
Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families:
- pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips;
- livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc.
Net sales are distributed geographically as follows: France (15.4%), Europe (26.2%), Latin America (17.1%), Asia (16.4%), North America (13.2%), Pacific (9.3%), Africa and Middle East (2.4%).
Sector
-
Consensus: Virbac
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
360
EUR
Average target price
382.3
EUR
Spread / Average Target
+6.20%
- Stock Market
- Certificates
- Certificat
